A critical role of retinoic acid concentration for the induction of a fully human-like atrial action potential phenotype in hiPSC-CM

Stem Cell Reports. 2023 Nov 14;18(11):2096-2107. doi: 10.1016/j.stemcr.2023.10.006. Epub 2023 Nov 2.

Abstract

Retinoic acid (RA) induces an atrial phenotype in human induced pluripotent stem cells (hiPSCs), but expression of atrium-selective currents such as the ultrarapid (IKur) and acetylcholine-stimulated K+ current is variable and less than in the adult human atrium. We suspected methodological issues and systematically investigated the concentration dependency of RA. RA treatment increased IKur concentration dependently from 1.1 ± 0.54 pA/pF (0 RA) to 3.8 ± 1.1, 5.8 ± 2.5, and 12.2 ± 4.3 at 0.01, 0.1, and 1 μM, respectively. Only 1 μM RA induced enough IKur to fully reproduce human atrial action potential (AP) shape and a robust shortening of APs upon carbachol. We found that sterile filtration caused substantial loss of RA. We conclude that 1 μM RA seems to be necessary and sufficient to induce a full atrial AP shape in hiPSC-CM in EHT format. RA concentrations are prone to methodological issues and may profoundly impact the success of atrial differentiation.

Keywords: IKUR; action potential; atrial differentiation; atrial hiPSC-CM; electrophysiology; engineered heart tissue; retinoid acid; ultrarapid repolarizing current.

MeSH terms

  • Action Potentials
  • Atrial Fibrillation* / metabolism
  • Heart Atria
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Myocytes, Cardiac
  • Phenotype
  • Tretinoin / metabolism
  • Tretinoin / pharmacology

Substances

  • Tretinoin